XML 92 R54.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Acquisitions and Dispositions - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
 1 Months Ended 12 Months Ended
Feb. 20, 2024
Apr. 01, 2023
Aug. 30, 2022
May 13, 2022
Jun. 30, 2021
Apr. 26, 2024
Apr. 28, 2023
Apr. 29, 2022
Business Acquisition [Line Items]                
Goodwill           $ 40,986 $ 41,425 $ 40,502
Purchase price contingent consideration           30 274  
Contingent consideration receivable           58 195  
Noncontrolling interests           206 182  
Asset impairments and related inventory write-downs           371 0 515
Cost of products sold           11,216 10,719 10,145
Other operating expense, net           $ (464) 131 (862)
Impairment of intangible asset indefinite lived excluding goodwill statement of income or comprehensive income extensible enumeration not disclosed flag           Other operating expense, net    
Contingent consideration           $ 149 206 $ 119
Other accrued expenses                
Business Acquisition [Line Items]                
Contingent consideration           96 34  
Other liabilities                
Business Acquisition [Line Items]                
Contingent consideration           $ 53 171  
Maximum                
Business Acquisition [Line Items]                
Intangible assets, estimated useful life           20 years    
Mozarc                
Business Acquisition [Line Items]                
Ownership percentage   50.00%       50.00%    
Mozarc                
Business Acquisition [Line Items]                
Noncontrolling interests   $ 307            
Renal Care Solutions | Other operating expense (income), net                
Business Acquisition [Line Items]                
Asset impairments and related inventory write-downs             $ 136  
Renal Care Solutions | Mozarc | Maximum                
Business Acquisition [Line Items]                
Contingent consideration receivable   300            
Disposal Group, Not Discontinued Operations | Ventilator Product Line Exit                
Business Acquisition [Line Items]                
Business exit costs $ 439              
Discontinued operation, other operating expense, net 369              
Cost of products sold, excluding amortization of intangible assets 70              
Non-cash impairments 371              
Impairment of indefinite-lived intangible assets 295              
Inventory write-down $ 70              
Disposal Group, Not Discontinued Operations | Renal Care Solutions | Mozarc                
Business Acquisition [Line Items]                
Proceeds from sale of businesses   45            
Contingent consideration receivable   195            
Payments to acquire long-term investments   $ 224            
Disposal Group, Not Discontinued Operations | Mechanical Circulatory Support                
Business Acquisition [Line Items]                
Business exit costs         $ 881      
Non-cash impairments         515      
Impairment of indefinite-lived intangible assets         409      
Inventory write-down         58      
Cost of products sold         58      
Other operating expense, net         823      
Other commitment         $ 366      
Business combinations                
Business Acquisition [Line Items]                
Total consideration for the transaction, net of cash acquired           $ 335    
Goodwill           131    
Goodwill, net of tax           51    
Goodwill, non deductible amount           80    
Business combinations | Technology-Based Intangible Assets                
Business Acquisition [Line Items]                
Intangible assets acquired           $ 29    
Intangible assets, estimated useful life           10 years    
Business combinations | IPR&D                
Business Acquisition [Line Items]                
Indefinite-lived intangible assets           $ 150    
Intersect ENT                
Business Acquisition [Line Items]                
Total consideration for the transaction, net of cash acquired       $ 1,200        
Goodwill       $ 615        
Intangible assets, estimated useful life       20 years        
Shares price (in dollars per share)       $ 28.25        
Cash consideration       $ 1,100        
Previously held investments in Intersect ENT       98        
Net assets acquired       1,277        
Intersect ENT | Technology-Based Intangible Assets                
Business Acquisition [Line Items]                
Intangible assets acquired       635        
Intersect ENT | Customer-related                
Business Acquisition [Line Items]                
Intangible assets acquired       35        
Intersect ENT | Trade Names                
Business Acquisition [Line Items]                
Intangible assets acquired       $ 13        
Affera                
Business Acquisition [Line Items]                
Total consideration for the transaction, net of cash acquired     $ 904          
Goodwill     660          
Contingent consideration liabilities     201          
Net assets acquired     970          
Affera | IPR&D                
Business Acquisition [Line Items]                
Indefinite-lived intangible assets     $ 300          
Other Acquisitions                
Business Acquisition [Line Items]                
Goodwill           66    
Purchase price contingent consideration           73    
Net assets acquired           123    
Other Acquisitions | Technology-Based Intangible Assets                
Business Acquisition [Line Items]                
Intangible assets acquired           $ 57    
Intangible assets, estimated useful life           16 years